The French medtech company Posos, which offers a medical decision support tool to customize medication management, was selected by the Ministry of Health as a study object to assess the medical-economic impact of detecting iatrogenics (risks in medical prescriptions) to emergencies.
The objective of the study is to show the interest of the digital tool for the detection of medication problems and their correction through more adequate care, to save time and reduce the physician’s mental workload. Unique at an international level, this work is aimed in particular at helping the hospital sector, which has been in crisis for several years, and more particularly emergency personnel who are overworked.
Posos, accompanied by the Digital Medical Hub, was selected, with the AP-HP and the CHU Amiens-Picardie, by the Ministry of Health to carry out the first French study on the medical-economic benefits of the detection of iatrogenesis in the emergency room . The scientific committee responsible for the study is headed by Dr. Aurélien Mary, clinical pharmacist at Amiens-Picardie University Hospital and Dr. Laure Abensur Vuillaume, emergency physician at the CHR in Metz-Thionville and brings together the expertise of several hospitals, including the AP-HP . This project, which should make it easier for emergency personnel to detect and correct risks in medical prescriptions, in particular thanks to AI, is part of the path mapped out in 2017 by the WHO to reduce iatrogenesis by 50% , and combating inadequacies in prescriptions is a priority of public health.
The objective of this study is threefold: to reduce the number of high-risk prescriptions – iatrogenic causes 10,000 deaths per year* and more than 130,000 hospitalizations -, to facilitate the day-to-day work of emergency teams and to reduce hospital costs associated with the risk of medication errors. In the hospital, a serious adverse event occurs every five days in a 30-bed ward, and in the context of emergency admissions, 40.6%*of patient prescriptions have preventable drug risks.* Half of these risks are preventable . This study, carried out over 24 months, will be implemented in two phases in emergency services. The first, in the simulation phase, will consist of placing a team of emergency physicians with Posos and another without to determine the clinical benefits of the tool; the second will take place in real life in hospitals for one year to evaluate the clinical and medico-economic advantages of the Posos medical device.
The situation in the emergency room continues to deteriorate. In 2018, in France, 72%* of doctors felt a lack of time to do their work. In the emergency room, 60% of emergency physicians have at least one symptom of burnout, a level of work overload reinforced by the closure of beds and services. These conditions make the work of caregivers particularly complex, especially in this medical specialty where consultation time is limited and where professionals are faced with a wide variety of antecedents and pathologies. AI-powered digital medical devices such as Posos are on a mission to enable teams to save time on patient admission through automation of transcription and analysis of prescriptions and research facilitated by patient-tailored therapeutic solutions. For 66.5%* of hospital doctors, they also help ease the mental burden.
*Report on the monitoring and proper use of medicines in France by B.Bégaud, D.Costagliola
*HAS annual report, 2018
*MOAT research by C. Geeson, L. Wei, BD Franklin
*Odoxa Research, 2018
*Posos barometer, performed on more than 2,500 caregivers, February 2022